[print friendly]

sitagliptin (JANUVIA)

• A Review of the ‘Gliptin’ Diabetes Drugs [hide all summaries]
  (March 2012)
  Find out why you should not use any of the three recently-approved diabetes drugs known as "gliptins".
• Review of Type-2 Diabetes Medication Liraglutide (VICTOZA) [hide all summaries]
  (April 2011)
  This article reviews the safety and efficacy of liraglutide (VICTOZA), a new medication used to treat type-2 diabetes.
• Saxagliptin (ONGLYZA) - Another Diabetes Drug [hide all summaries]
  (February 2011)
  This article discusses why you should not use this newly approved diabetes drug until more is known about its safety.
• Oral Drugs for Diabetes: Avoiding Hypoglycemia [hide all summaries]
  (May 2010)
  After explaining the symptoms of low blood sugar (hypoglycemia) the article lists 42 prescription drugs that can interact with one or more diabetes drugs to increase the chance of hypoglycemia.
• Type 2 Diabetes Drugs Fail to Improve the Most Serious Long-Term Complications [hide all summaries]
  (February 2010)
  The article discusses why all of these 16 diabetes drugs carry a label stating: "There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction [heart attacks, strokes, etc] with oral antidiabetic drug[s]." The article also explains why lifestlyle changes such as diet and exercise to prevent or even treat type II diabetes are not heavily promoted or usually reimbursed.
• Update: Diabetes Drug JANUVIA (Sitagliptin) [hide all summaries]
  (July 2008)
  An increasing body of evidence documents both the risks and lack of evidence of clinical benefits associated with sitagliptin, and several reviews have cautioned against its use.
• Sitagliptin (JANUVIA) for Type-2 Diabetes [hide all summaries]
  (June 2007)
  Worst Pills, Best Pills reviews side effects and long-term effects of type-2 diabetes drug sitagliptin (JANUVIA) in this article.

SHOW secondary search results for sitagliptin (JANUVIA)